| ||||||||||||
|
||||||||||||
|
The TEDS Report - Substance Abuse Treatment Admissions for Abuse of Benzodiazepines
Highlights: The number of benzodiazepine admissions nearly tripled between 1998 and 2008, while overall treatment admissions increased only 11 percent. The majority of benzodiazepine admissions were male, between the ages of 18 and 34, or non-Hispanic White. Almost all benzodiazepine admissions (95 percent) reported abuse of another substance in addition to abuse of benzodiazepines: 82.1 percent reported primary abuse of another substance with secondary abuse of benzodiazepines, and 12.9 percent reported primary abuse of benzodiazepines with secondary abuse of another substance. Other OAS publications and services This Short ,The TEDS Report - Substance Abuse Treatment Admissions for Abuse of Benzodiazepines, is based on SAMHSA's Drug and Alcohol Services Information System (DASIS), conducted by SAMHSA's Office of Applied Studies (OAS) in the Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA's National Survey on Drug Use and Health is the primary source of information on the prevalence, patterns, and consequences of drug and alcohol use and abuse in the general U.S. civilian non institutionalized population, age 12 and older. SAMHSA's National Survey on Drug Use & Health also provides estimates for drug use by State. |
This page has been accessed 2730 times since 6/9/11. This page was last updated on June 9, 2011. |
SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.
* PDF formatted files require that Adobe Acrobat ReaderĀ® program is installed on your computer. Click here to download this FREE software now from Adobe. |